Cost‐effectiveness analysis of tislelizumab in combination with chemotherapy for the first‐line treatment of patients with metastatic or recurrent nasopharyngeal carcinoma in China
Article in Head & Neck (October 2023)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Potent predictive CpG signature for temozolomide response in non-glioma-CpG island methylator phenotype glioblastomas with methylated MGMT promoter
Article in Epigenomics (October 2022)
Integrative analysis of CBR1 as a prognostic factor associated with IDH-mutant glioblastoma in the Chinese population.
Article in American Journal of Translational Research (August 2022)